Yoshio Hosoi

Dr. Yoshio Hosoi

Department of Radiation Biology, Tohoku University, Sendai, Miyagi, Japan
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in The Lancet
Verified
Journal Article
Closed access
KTKoichi Tanigawa
Koichi Tanigawa
YHYoshio Hosoi
Yoshio Hosoi
NHNobuyuki Hirohashi
Nobuyuki Hirohashi
YIYasumasa Iwasaki
Yasumasa Iwasaki
KKKenji Kamiya
Kenji Kamiya

1 August 2004 in International Journal of Oncology
Verified
Journal Article
Closed access
PDF file
YHYoshio Hosoi
Yoshio Hosoi
TWToshiaki Watanabe
Toshiaki Watanabe
KNKeiichi Nakagawa
Keiichi Nakagawa
Yoshihisa MatsumotoYoshihisa Matsumoto
Yoshihisa Matsumoto
AEAtsushi Enomoto
Atsushi Enomoto
NSNorio Suzuki
Norio Suzuki
Tumor tissues and adjacent normal tissues in 12 colorectal cancers were examined for quantitative differences in: i) activity of DNA-dependent protein kinase (DNA-PK), which functions in DNA double-strand breads repair, and ii) protein and mRNA levels of Ku70, Ku80, DNA-PKcs and transcriptional factor Sp1. DNA-PK activity and protein/mRNA levels of Ku70, Ku80, DNA-PKcs and Sp1 were significantly higher in the tumor tissues compared with the normal tissues. Significant correlations between DNA-PK activity and protein/mRNA levels of Ku70, Ku80, DNA-PKcs and Sp1 were observed. Because Ku80 and DNA-PKcs have consensus Sp1 recognition elements in their promoter region, the DNA sequence of Ku70 promoter region was analyzed. Analysis of Ku70 promoter region reveled that Ku70 gene has consensus Sp1 recognition elements in its promoter region. mRNA levels of Ku70, Ku80 and DNA-PKcs were correlated with one another, and significant correlations between Sp1 protein level and mRNA levels of Ku70 and Ku80 were observed. These results suggest that DNA-PK activity and protein- and mRNA-levels of Ku70, Ku80 and DNA-PKcs were elevated in tumor tissues in patients with colorectal cancer because of elevated Sp1 protein levels in tumor tissues.

5 September 2002 in Cancer
Verified
Journal Article
Open access
PDF file
YKYasuhiro Komuro
Yasuhiro Komuro
TWToshiaki Watanabe
Toshiaki Watanabe
YHYoshio Hosoi
Yoshio Hosoi
Yoshihisa MatsumotoYoshihisa Matsumoto
Yoshihisa Matsumoto
KNKeiichi Nakagawa
Keiichi Nakagawa
HNHirokazu Nagawa
Hirokazu Nagawa
BACKGROUND: Preoperative radiotherapy reduces the rate of local recurrence and improves the chance of survival in patients with resectable, advanced rectal carcinoma. However, because not all tumors respond similarly to radiation, sorting out suitable patients is required to irradiate tumors rationally. The authors examined the possible role of Ku protein in determining tumor radiosensitivity and disease free survival in patients with rectal carcinoma.METHODS: The authors studied 96 patients with advanced rectal carcinoma. In preradiation biopsy specimens of tumor samples, the number of cells that were stained positive for Ku protein was evaluated by immunohistochemistry. The expression pattern of Ku protein was examined for an association between tumor radiosensitivity (which was determined according to T classification downstaging, complete pathologic response, or Response Evaluation Criteria in Solid Tumors) and disease free survival.RESULTS: There was a high degree of correlation between the percentage of cells that expressed the 70‐kDa Ku protein (Ku70) and the 86‐kDa Ku protein (Ku86) in the tumor sections (correlation coefficient = 0.85; P < 0.001). The expression pattern of Ku protein was correlated not only with tumor radiosensitivity but also with disease free survival. Pathologic TMN classification, histopathologic grade, and Ku70 expression were significant prognostic variables for disease free survival in a multivariate analysis (P = 0.0031, P = 0.030, and P = 0.023, respectively).CONCLUSIONS: Ku70 and Ku86 raise the predictive possibility of tumor radiosensitivity. Ku may be a useful parameter for selecting patients with rectal carcinoma for preoperative radiotherapy. Cancer 2002;95:1199–205. © 2002 American Cancer Society.DOI 10.1002/cncr.10807

1 February 2000 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
TOTetsuya Ono
Tetsuya Ono
HIHironobu Ikehata
Hironobu Ikehata
SNShingo Nakamura
Shingo Nakamura
YSYusuke Saito
Yusuke Saito
YHYoshio Hosoi
Yoshio Hosoi
KYKazuo Yamamoto
Kazuo Yamamoto

1 February 1993 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
PDF file
YHYoshio Hosoi
Yoshio Hosoi
KSK. Sakamoto
K. Sakamoto

1 December 2006 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
HYHideomi Yamashita
Hideomi Yamashita
KNKeiichi Nakagawa
Keiichi Nakagawa
NNNaoki Nakamura
Naoki Nakamura
KAKeiko Abe
Keiko Abe
TATakahiro Asakage
Takahiro Asakage
KOKuni Ohtomo
Kuni Ohtomo